Cart summary

You have no items in your shopping cart.

Palivizumab

Palivizumab

Catalog Number: orb1980537

DispatchUsually dispatched within 5-10 working days
$ 330.00
Catalog Numberorb1980537
CategoryAntibodies
DescriptionPalivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
ClonalityMonoclonal
CAS Number188039-54-5
Concentration4.26 mg/mL
Purity97.6% (SEC-HPLC)
ConjugationUnconjugated
MW144.99 kDa
TargetPalivizumab
Biological ActivityPalivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
NoteFor research use only
Expiration Date12 months from date of receipt.
  • Anti-RSV-F Reference Antibody (palivizumab) [orb1818086]

    ELISA,  FC

    Human, Monkey, Mouse

    Monoclonal

    Unconjugated

    100 μg
  • Anti-RSV-F Reference Antibody (palivizumab) [orb1805413]

    ELISA,  FA,  FACS,  Kinetics

    Virus

    Monoclonal

    Unconjugated

    50 μg, 100 μg, 1 mg, 5 mg
  • Palivizumab [orb1290232]

    ELISA

    Human

    Mouse

    Monoclonal

    Unconjugated

    100 μg, 1 mg
  • Palivizumab (RSV) - Research Grade Biosimilar [orb1237460]

    Recombinant

    Unconjugated

    0.1 mg
  • Palivizumab [orb1141284]

    Unconjugated

    5 mg, 1 mg